Skip to main content
Erschienen in: World Journal of Surgery 9/2013

01.09.2013

Postoperative Complications Influence Prognosis and Recurrence Patterns in Periampullary Cancer

verfasst von: Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Dae Wook Hwang, Kyuwhan Jung, Young Ki Kim

Erschienen in: World Journal of Surgery | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The present study was performed to elucidate the influence of postoperative complications on the prognosis and recurrence patterns of periampullary cancer after pancreaticoduodenectomy (PD).

Methods

Clinical data were reviewed from 200 consecutive patients who had periampullary cancer and underwent PD between October 2003 and July 2010, and survival outcomes and recurrence patterns were analyzed. Postoperative complications were classified according to a modification of Clavien’s classification.

Results

Overall, 86 major complications of grade II or higher occurred in 71 patients. The patients were classified into two groups according to the presence of postoperative complications of grade II or higher: group Cx−, absence of complications (n = 129); and group Cx+, presence of complications (n = 71). There were no differences in gender, mean age, tumor node metastasis stage, biliary drainage, type of resection, and radicality between the two groups (P > 0.05). The 3-year overall and disease-free survival rates of the group Cx+ patients (31.0 and 22.3 %, respectively) were significantly lower than those of the group Cx− patients (49.0 and 40.0 %; P = 0.003 and 0.002, respectively). The multivariate analysis showed that postoperative complications (P = 0.001; RR = 1.887; 95 % confidence interval [CI] 1.278–2.785), a T stage of T3 or T4 (P = 0.001; RR = 2.503; 95 % CI 1.441–4.346), positive node metastasis (P = 0.001; RR = 2.093; 95 % CI, 1.378–3.179), R1 or R2 resection (P = 0.023; RR = 1.863; 95 % CI 1.090–3.187), and angiolymphatic invasion (P = 0.013; RR = 1.676; 95 % CI 1.117–2.513) were independent prognostic factors for disease-free survival. Regarding recurrence patterns, group Cx+ patients exhibited more distant recurrences than did group Cx− patients (P = 0.025).

Conclusions

Postoperative complications affect prognosis and recurrence patterns in patients with periampullary cancer after PD.
Literatur
1.
Zurück zum Zitat Hatzaras I, George N, Muscarella P et al (2010) Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol 17:991–997PubMedCrossRef Hatzaras I, George N, Muscarella P et al (2010) Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol 17:991–997PubMedCrossRef
2.
Zurück zum Zitat Balcom JHT, Rattner DW, Warshaw AL et al (2001) Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136:391–398PubMedCrossRef Balcom JHT, Rattner DW, Warshaw AL et al (2001) Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136:391–398PubMedCrossRef
3.
Zurück zum Zitat Yeo CJ, Cameron JL, Maher MM et al (1995) A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222:580–588 discussion 588–592PubMed Yeo CJ, Cameron JL, Maher MM et al (1995) A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222:580–588 discussion 588–592PubMed
4.
Zurück zum Zitat Buchler MW, Friess H, Wagner M et al (2000) Pancreatic fistula after pancreatic head resection. Br J Surg 87:883–889PubMedCrossRef Buchler MW, Friess H, Wagner M et al (2000) Pancreatic fistula after pancreatic head resection. Br J Surg 87:883–889PubMedCrossRef
5.
Zurück zum Zitat Sato N, Yamaguchi K, Chijiiwa K et al (1998) Risk analysis of pancreatic fistula after pancreatic head resection. Arch Surg 133:1094–1098PubMedCrossRef Sato N, Yamaguchi K, Chijiiwa K et al (1998) Risk analysis of pancreatic fistula after pancreatic head resection. Arch Surg 133:1094–1098PubMedCrossRef
6.
Zurück zum Zitat Khuri SF, Henderson WG, DePalma RG et al (2005) Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 242:326–341 discussion 341–343PubMed Khuri SF, Henderson WG, DePalma RG et al (2005) Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 242:326–341 discussion 341–343PubMed
7.
Zurück zum Zitat Law WL, Choi HK, Lee YM, Ho JW (2007) The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 14:2559–2566PubMedCrossRef Law WL, Choi HK, Lee YM, Ho JW (2007) The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 14:2559–2566PubMedCrossRef
8.
Zurück zum Zitat Crozier JE, McKee RF, McArdle CS et al (2007) Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg 94:1028–1032PubMedCrossRef Crozier JE, McKee RF, McArdle CS et al (2007) Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg 94:1028–1032PubMedCrossRef
9.
Zurück zum Zitat Jamieson GG, Thompson SK (2009) Detection of lymph node metastases in oesophageal cancer. Br J Surg 96:21–25PubMedCrossRef Jamieson GG, Thompson SK (2009) Detection of lymph node metastases in oesophageal cancer. Br J Surg 96:21–25PubMedCrossRef
10.
Zurück zum Zitat Murri AM, Hilmy M, Bell J et al (2008) The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer 99:1013–1019PubMedCrossRef Murri AM, Hilmy M, Bell J et al (2008) The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer 99:1013–1019PubMedCrossRef
11.
Zurück zum Zitat Han HS, Cho JY, Yoon YS et al (2011) Preoperative inflammation is a prognostic factor for gallbladder carcinoma. Br J Surg 98:111–116PubMedCrossRef Han HS, Cho JY, Yoon YS et al (2011) Preoperative inflammation is a prognostic factor for gallbladder carcinoma. Br J Surg 98:111–116PubMedCrossRef
12.
Zurück zum Zitat Cho JY, Han HS, Yoon YS et al (2012) Preoperative cholangitis and metastatic lymph node have negative impact on survival after resection of extrahepatic bile duct cancer. World J Surg 36:1842–1847. doi:10.1007/s00268-012-1594-0 PubMedCrossRef Cho JY, Han HS, Yoon YS et al (2012) Preoperative cholangitis and metastatic lymph node have negative impact on survival after resection of extrahepatic bile duct cancer. World J Surg 36:1842–1847. doi:10.​1007/​s00268-012-1594-0 PubMedCrossRef
13.
Zurück zum Zitat Clavien PA, Camargo CA Jr, Croxford R et al (1994) Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg 220:109–120PubMedCrossRef Clavien PA, Camargo CA Jr, Croxford R et al (1994) Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg 220:109–120PubMedCrossRef
14.
Zurück zum Zitat Cho JY, Suh KS, Kwon CH et al (2006) Outcome of donors with a remnant liver volume of less than 35 % after right hepatectomy. Liver Transpl 12:201–206PubMedCrossRef Cho JY, Suh KS, Kwon CH et al (2006) Outcome of donors with a remnant liver volume of less than 35 % after right hepatectomy. Liver Transpl 12:201–206PubMedCrossRef
15.
Zurück zum Zitat Cho JY, Suh KS, Kwon CH et al (2006) Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 139:508–515PubMedCrossRef Cho JY, Suh KS, Kwon CH et al (2006) Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 139:508–515PubMedCrossRef
16.
Zurück zum Zitat Yi NJ, Suh KS, Cho JY et al (2007) Three-quarters of right liver donors experienced postoperative complications. Liver Transpl 13:797–806PubMedCrossRef Yi NJ, Suh KS, Cho JY et al (2007) Three-quarters of right liver donors experienced postoperative complications. Liver Transpl 13:797–806PubMedCrossRef
17.
Zurück zum Zitat Katz MH, Wang H, Balachandran A et al (2011) Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. J Gastrointest Surg 16:68–79PubMedCrossRef Katz MH, Wang H, Balachandran A et al (2011) Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. J Gastrointest Surg 16:68–79PubMedCrossRef
18.
Zurück zum Zitat Hur S, Yoon CJ, Kang SG et al (2011) Transcatheter arterial embolization of gastroduodenal artery stump pseudoaneurysms after pancreaticoduodenectomy: safety and efficacy of two embolization techniques. J Vasc Interv Radiol 22:294–301PubMedCrossRef Hur S, Yoon CJ, Kang SG et al (2011) Transcatheter arterial embolization of gastroduodenal artery stump pseudoaneurysms after pancreaticoduodenectomy: safety and efficacy of two embolization techniques. J Vasc Interv Radiol 22:294–301PubMedCrossRef
19.
Zurück zum Zitat Wagner M, Redaelli C, Lietz M et al (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:494–586CrossRef Wagner M, Redaelli C, Lietz M et al (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:494–586CrossRef
20.
Zurück zum Zitat Schafer M, Mullhaupt B, Clavien PA (2002) Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 236:137–148PubMedCrossRef Schafer M, Mullhaupt B, Clavien PA (2002) Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 236:137–148PubMedCrossRef
21.
Zurück zum Zitat Nitecki SS, Sarr MG, Colby TV et al (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59–66PubMedCrossRef Nitecki SS, Sarr MG, Colby TV et al (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59–66PubMedCrossRef
22.
Zurück zum Zitat Han SS, Jang JY, Kim SW et al (2006) Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 32:271–275PubMedCrossRef Han SS, Jang JY, Kim SW et al (2006) Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 32:271–275PubMedCrossRef
23.
Zurück zum Zitat Yeo CJ, Sohn TA, Cameron JL et al (1998) Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227:821–831PubMedCrossRef Yeo CJ, Sohn TA, Cameron JL et al (1998) Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227:821–831PubMedCrossRef
24.
Zurück zum Zitat Yeo CJ, Cameron JL, Sohn TA et al (1999) Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229:613–622 discussion 622–624PubMedCrossRef Yeo CJ, Cameron JL, Sohn TA et al (1999) Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229:613–622 discussion 622–624PubMedCrossRef
25.
Zurück zum Zitat Riall TS, Cameron JL, Lillemoe KD et al (2006) Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140:764–772PubMedCrossRef Riall TS, Cameron JL, Lillemoe KD et al (2006) Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140:764–772PubMedCrossRef
26.
Zurück zum Zitat Nakao A, Harada A, Nonami T et al (1995) Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg 82:399–402PubMedCrossRef Nakao A, Harada A, Nonami T et al (1995) Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg 82:399–402PubMedCrossRef
27.
Zurück zum Zitat Chan C, Herrera MF, de la Garza L et al (1995) Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg 222:632–637PubMedCrossRef Chan C, Herrera MF, de la Garza L et al (1995) Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg 222:632–637PubMedCrossRef
28.
Zurück zum Zitat Howard TJ, Krug JE, Yu J et al (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10:1338–1345 discussion 1345–1346PubMedCrossRef Howard TJ, Krug JE, Yu J et al (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10:1338–1345 discussion 1345–1346PubMedCrossRef
29.
Zurück zum Zitat Kang CM, Kim DH, Choi GH et al (2009) Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas. J Gastrointest Surg 13:907–914PubMedCrossRef Kang CM, Kim DH, Choi GH et al (2009) Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas. J Gastrointest Surg 13:907–914PubMedCrossRef
30.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13PubMedCrossRef Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13PubMedCrossRef
31.
Zurück zum Zitat Murthy BL, Thomson CS, Dodwell D et al (2007) Postoperative wound complications and systemic recurrence in breast cancer. Br J Cancer 97:1211–1217PubMedCrossRef Murthy BL, Thomson CS, Dodwell D et al (2007) Postoperative wound complications and systemic recurrence in breast cancer. Br J Cancer 97:1211–1217PubMedCrossRef
32.
Zurück zum Zitat Kressner U, Graf W, Mahteme H et al (2002) Septic complications and prognosis after surgery for rectal cancer. Dis Colon Rectum 45:316–321PubMedCrossRef Kressner U, Graf W, Mahteme H et al (2002) Septic complications and prognosis after surgery for rectal cancer. Dis Colon Rectum 45:316–321PubMedCrossRef
33.
Zurück zum Zitat Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545PubMedCrossRef Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545PubMedCrossRef
34.
Zurück zum Zitat Abramovitch R, Marikovsky M, Meir G et al (1999) Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 79:1392–1398PubMedCrossRef Abramovitch R, Marikovsky M, Meir G et al (1999) Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 79:1392–1398PubMedCrossRef
35.
Zurück zum Zitat Menetrier-Caux C, Montmain G, Dieu MC et al (1998) Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92:4778–4791PubMed Menetrier-Caux C, Montmain G, Dieu MC et al (1998) Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92:4778–4791PubMed
36.
Zurück zum Zitat Bogden AE, Moreau JP, Eden PA (1997) Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 75:1021–1027PubMedCrossRef Bogden AE, Moreau JP, Eden PA (1997) Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 75:1021–1027PubMedCrossRef
37.
Zurück zum Zitat Raa ST, Oosterling SJ, van der Kaaij NP et al (2005) Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters. J Surg Oncol 92:124–129PubMedCrossRef Raa ST, Oosterling SJ, van der Kaaij NP et al (2005) Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters. J Surg Oncol 92:124–129PubMedCrossRef
38.
Zurück zum Zitat Jacobi CA, Ordemann J, Zieren HU et al (1998) Increased systemic inflammation after laparotomy vs laparoscopy in an animal model of peritonitis. Arch Surg 133:258–262PubMedCrossRef Jacobi CA, Ordemann J, Zieren HU et al (1998) Increased systemic inflammation after laparotomy vs laparoscopy in an animal model of peritonitis. Arch Surg 133:258–262PubMedCrossRef
39.
Zurück zum Zitat van den Tol PM, van Rossen EE, van Eijck CH et al (1998) Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 227:242–248PubMedCrossRef van den Tol PM, van Rossen EE, van Eijck CH et al (1998) Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 227:242–248PubMedCrossRef
40.
Zurück zum Zitat van den Tol MP, ten Raa S, van Grevenstein WM et al (2007) The post-surgical inflammatory response provokes enhanced tumour recurrence: a crucial role for neutrophils. Dig Surg 24:388–394PubMedCrossRef van den Tol MP, ten Raa S, van Grevenstein WM et al (2007) The post-surgical inflammatory response provokes enhanced tumour recurrence: a crucial role for neutrophils. Dig Surg 24:388–394PubMedCrossRef
Metadaten
Titel
Postoperative Complications Influence Prognosis and Recurrence Patterns in Periampullary Cancer
verfasst von
Jai Young Cho
Ho-Seong Han
Yoo-Seok Yoon
Dae Wook Hwang
Kyuwhan Jung
Young Ki Kim
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 9/2013
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2106-6

Weitere Artikel der Ausgabe 9/2013

World Journal of Surgery 9/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.